Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
Berry-flavored, non-GMO, gluten-free, and easy to usejust drop in water, let it fizz, and enjoy
GSH activated biotin-tagged near-infrared probe for efficient cancer imaging
Essentially, your gut may have lost beneficial bacteria, be overrun with bad bacteria, or may lack bacteria diversity
If you are worried about sweating then this product isnt for you as it is designed to help you sweat